{
    "id": 16051,
    "cites": 6,
    "cited_by": 2,
    "reference": [
        "Bailar J, Gornik H (1997), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Cancer undefeated,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d New England Journal of Medicine 336 (22), pp. 1569-74.",
        "Barocas DA, Mitchell R, Chang SS, Cookson MS (2009), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Impact of surgeon and hospital volume on outcomes of radical prostatectomy,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Urol Oncol. Apr 21. Honor\u00c3\u0083\u00c6\u0092\u00c3\u0082\u00c2\u00a9, Bo, and Adriana \u00c3\u0083\u00e2\u0080\u00a1\u00c3\u0082\u00c2\u00a6\u00c3\u0083\u00cb\u0086\u00c3\u0082\u00e2\u0080\u00b9\u00c3\u0083\u00c2\u008d\u00c3\u0082\u00c2\u00b4\u00c3\u0083\u00c2\u008d\u00c3\u0082\u00c2\u00b2\u00c3\u0083\u00c2\u008d\u00c3\u0082\u00c2\u00b2\u00c3\u0083\u00c2\u008d\u00c3\u0082\u00c2\u00b8\u00c3\u0083\u00cb\u0086\u00c3\u0082\u00c5\u0092\u00c3\u0083\u00e2\u0080\u00a1\u00c3\u0082\u00c2\u00a1\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Competing Risks and the War on Cancer,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Econometrica, Vol. 74, Issue 6, November.",
        "Leaf, Clifton (2004), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Why we\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00e2\u0084\u00a2re losing the war on cancer, and how to win it,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Fortune, March 22 <http://blog.aperio.com/articles/Fortune_Cancer.pdf> Lichtenberg, Frank R. (2007), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Importation and innovation,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Economics of Innovation and New Technology 16(6), September, pp. 403\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00e2\u0080\u009c417.",
        "Lichtenberg, Frank R. (2009a), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d Economics of Innovation and New Technology 18 (5), 407-28.",
        "Lichtenberg, Frank R. (2009b), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093International differences in cancer survival rates: the role of new drug launches,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d International Journal of Healthcare Technology and Management 10 (3), 138-55.",
        "Lichtenberg, Frank R., and Joel Waldfogel (2009), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Does Misery Love Company? Evidence from Pharmaceutical Markets before and after the Orphan Drug Act,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d 15 Mich. Telecomm. Tech. L. Rev., available at http://www.mttlr.org/volfifteen/lichtenberg&waldfogel.pdf Welch, H. Gilbert, Lisa M. Schwartz, and Steven Woloshin (2000), \u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c5\u0093Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer?,\u00c3\u0083\u00c2\u00a2\u00c3\u0082\u00e2\u0082\u00ac\u00c3\u0082\u00c2\u009d JAMA 283(22): 2975-2978 (doi:10.1001/jama.283.22.2975)"
    ]
}